Faculty
Kim Margolin, MD
Professor
Department of Medicine
Division of Oncology
Mailing Address
Seattle Cancer Care Alliance
825 Eastlake Ave E
Seattle, WA 98109
Admin Contact
Sandra Bergevin
206.288.7341
Specialty / Expertise
Melanoma, Renal, and Germ Cell Cancer
Research Interests
N/A
Current Research Projects
N/A
Training
Dr. Margolin received her MD from Stanford University, Stanford, CA. She completed her Internal Medicine Residency at Yale New Haven Hospital, New Haven, CT. She was a Post-Doctoral Fellow in Hematology/Oncology at University of California, Sand Diego, San Diego, CA. She was a Post-Doctoral Fellow in Hematology and Bone Marrow Transplantation at City of Hope National Medical Center, Duarte, CA.
Selected Publications
Sosman JA, Carrillo, C, Urba, WJ, Flaherty, L, Atkins, MB, Clark, J, Dutcher, J, Margolin, KA, Mier, J, Gollob, J, Weiss, G, Kirkwood, J, Panka, D, LaFleur, B, Ernstoff, MS, A Cytokine Working Group (CWG) three-arm phase II trial of gp100 (210M)-peptide plus high-dose Interleukin-2 in HLA-A2+ advanced melanoma patients Journal Of Clinical Oncology (in press)
Clark, J; Mehrabi, J, Sosman, J, Logan, T, Margolin, K, Dutcher, J, Urba, Ernstoff, M, McDermott, D, Lau, A, Atkins, M Phase I/II Trial of Outpatient PEG-interferon With Interleukin-2 in Advanced Renal Cell Carcinoma: A Cytokine Working Group Study J Immunother 30: 839-846, 2007
Kavanagh, B, Andrew, K, Venook, A, Margolin, K, Zeh, H, Lotze, M, Schillinger, B, Liu, W, Lu, Y, Mitsky, P, Bercovici, N, Bender, J, Mills, B, Fong, L Vaccination of Metastatic Colorectal Cancer Patients with Matured Dendritic Cells Loaded with Multiple Major Histocompatibility Complex Class 1 Peptides Journal of Immunotherapy, 30: 762-772, 2007
Motzer R, Michaelson D, Rosenberg J, Bukowski R, Curti B, George D, Hudes G, Redman B, Margolin K, Merchan J, Wilding G Sunitinib Efficacy in a Pivotal Trial for Advanced Renal Cell Carcinoma Journal of Urology, 178: 1883-1887, 2007
Margolin K, Synold T, Lara P, Frankel P, Lacey S, Quinn D, Baratta T, Dutcher J, Xi B, Diamond D, Gandara D Oblimersen and α-Interferon in Metastatic Renal Cancer: a Phase II Study of the California Cancer Consortium J Cancer Res and Clin Oncol, 133: 705-711, 2007
Last updated: Oct 2011